Invion Expands Share Issuance and Eyes Technology Rights
Company Announcements

Invion Expands Share Issuance and Eyes Technology Rights

Invion Ltd. (AU:IVX) has released an update.

Invion Limited has announced the issuance of 50 million new shares, priced at $0.002 each, as part of its ongoing development of Photosoft technology for cancer treatment. The company is in early discussions with RMW Cho Group Limited to potentially expand its technology rights. Invion’s innovative approach in the field of photodynamic therapy could offer a promising alternative to conventional cancer treatments.

For further insights into AU:IVX stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskInvion Limited Reports Promising Cancer Trial Results
TipRanks Australian Auto-Generated NewsdeskInvion Ltd. Issues 50 Million New Shares on ASX
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App